DR. MARGARET PEARSON ADAM, MD, MS
Medical Practice at Sand Point Way, Seattle, WA
License number
Washington MD 60094938
Category
Medical Practice
Type
Clinical Genetics (M.D.)
License number
Washington MD 60094938
Category
Medical Practice
Type
Pediatrics
Address
Address
4800 Sand Point Way NE, Seattle, WA 98105
Phone
(206) 987-2689
(206) 987-2495 (Fax)
(206) 987-2495 (Fax)
Personal information
See more information about MARGARET PEARSON ADAM at radaris.comName
Address
Phone
7332 Keen Way N, Seattle, WA 98103
7332 Keen Way, Seattle, WA 98103
1100 9Th St, Seattle, WA 98101
Professional information
See more information about MARGARET PEARSON ADAM at trustoria.com
Margaret Pearson Adam, Seattle WA
Margaret Pearson Adam, Seattle WA
Specialties:
Pediatrician
Address:
4800 Sand Point Way Ne, Seattle, WA 98105
Board certifications:
American Board of Medical Genetics Certification in Clinical Genetics (MD) (Medical Genetics), American Board of Pediatrics Certification in Pediatrics
Margaret M Adam, Seattle WA
Margaret M Adam, Seattle WA
Specialties:
Internist
Address:
1930 Post Aly, Seattle, WA 98101
1100 9Th Ave, Seattle, WA 98101
1100 9Th Ave, Seattle, WA 98101
Education:
University of Connecticut, School of Medicine - Doctor of Medicine
George Washington University Hospital, The - Fellowship - Internal Medicine
Temple University Hospital - Residency - Internal Medicine
George Washington University Hospital, The - Fellowship - Internal Medicine
Temple University Hospital - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine
Dr. Margaret P Adam, Decatur GA - MD (Doctor of Medicine)
Dr. Margaret P Adam, Decatur GA - MD (Doctor of Medicine)
Specialties:
Pediatrics, Clinical Genetics
Address:
2165 N Decatur Rd, Decatur 30033
(404) 778-8530 (Phone), (404) 778-8562 (Fax)
SEATTLE CHILDRENS HOSPITAL
4800 Sand Point Way NE, Seattle 98105
(206) 987-2000 (Phone)
(404) 778-8530 (Phone), (404) 778-8562 (Fax)
SEATTLE CHILDRENS HOSPITAL
4800 Sand Point Way NE, Seattle 98105
(206) 987-2000 (Phone)
Certifications:
Clinical Genetics, 2005, Pediatrics, 2002
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Stanford University
Graduated: 1997
Stanford University
Graduated: 1997
Margaret P Adam, Seattle WA
Margaret P Adam, Seattle WA
Specialties:
Pediatrics, Medical Genetics, Clinical Genetics, M.D., Neurology
Work:
Seattle Children's Hospital
4800 Sand Point Way NE, Seattle, WA 98105
4800 Sand Point Way NE, Seattle, WA 98105
Education:
Stanford University (1998)
Dr. Margaret R Adam - MD (Doctor of Medicine)
Dr. Margaret R Adam - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Certifications:
Internal Medicine, 1993
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Neighborcare Health
1930 Post Aly, Seattle 98101
Neighborcare Health
1930 Post Aly, Seattle 98101
1930 Post Aly, Seattle 98101
Neighborcare Health
1930 Post Aly, Seattle 98101
Education:
Medical School
Univ Of Ct Sch Of Med
Graduated: 1990
Temple University Hospital
George Washington University
Univ Of Ct Sch Of Med
Graduated: 1990
Temple University Hospital
George Washington University
Margaret Rode Adam, Seattle WA
Margaret Rode Adam, Seattle WA
Specialties:
General Practice, Internal Medicine
Work:
Pike Market Medical Clinic
1930 Post Aly, Seattle, WA 98101
1930 Post Aly, Seattle, WA 98101
Education:
University of Connecticut(1990)
Methods And Compositions For Dmxl-Associated Mental Retardation
Methods And Compositions For Dmxl-Associated Mental Retardation
US Patent:
2010013, Jun 3, 2010
Filed:
Oct 22, 2009
Appl. No.:
12/589355
Inventors:
Madhuri Hegde - Lilburn GA, US
Margaret Adam - Seattle WA, US
Margaret Adam - Seattle WA, US
International Classification:
C12Q 1/68, C12P 19/34
US Classification:
435 6, 435 912
Abstract:
The present invention provides a method of identifying a human subject as having an increased likelihood of having DMXL-associated mental retardation, comprising detecting, in a nucleic acid sample from the subject, a mutation in a nucleotide sequence encoding DMXL1 and/or a mutation in a nucleotide sequence encoding DMXL2. The present invention further provides a method of identifying a human subject as having an increased likelihood of having DMXL-associated mental retardation, comprising detecting, in a sample from the subject, a mutation in a DMXL1 protein and/or a mutation in a DMXL2 protein.